Levothyroxine Supplier-Buyer Network — Trade Flow Analysis

Name: Levothyroxine Supplier-Buyer Trade Network Dataset — 125+ Indian Exporters, 14+ Importers, 71+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Levothyroxine supplier network, Levothyroxine buyers, pharmaceutical export India, Levothyroxine trade data

TransData Nexus

Levothyroxine

India Pharmaceutical Trade Intelligence

$77.7M125 Suppliers71 CountriesHS 30049099

ExportsIndia → UNITED STATES63.6%India → PERU11.6%

ImportsUNITED STATES → India$551.1K BELGIUM → India$196.2K

#1 Buyer: MACLEODS PHARMA

Who Supplies Levothyroxine? Top Manufacturers & Buyers 2026 — MACLEODS PHARMACEUTICALS LTD Leads | TransData Nexus | TransData Nexus

1MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the first-largest Levothyroxine exporter from India, with a market share of 31.0% and a total export value of $24.0M across 278 shipments. Their average shipment value of $86.5K is above the market average of $32.6K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MACLEODS PHARMA USA,INC, is the dominant customer, accounting for 89.9% of this supplier's tracked business. Top customers include:

• MACLEODS PHARMA USA,INC, — $21.6M across 250 shipments (89.9% of this supplier's total exports)

• APOTEX INC. - SIGNET — $804.1K across 9 shipments (3.3% of this supplier's total exports)

• NORTHSTAR DISTRIBUTI — $630.5K across 7 shipments (2.6% of this supplier's total exports)

• MACLEODS PHARMA USA,INC, — $568.6K across 7 shipments (2.4% of this supplier's total exports)

• MACLEODS PHARMA USA,INC, — $425.4K across 5 shipments (1.8% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $86.5K is 166% above the market average of $32.6K, consistent with large-order contracts or value-added formulations.

2INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the second-largest Levothyroxine exporter from India, with a market share of 11.6% and a total export value of $9.0M across 589 shipments. Their average shipment value of $15.4K is below the market average of $32.6K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 58.2% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $5.3M across 343 shipments (58.2% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES — $2.9M across 188 shipments (31.9% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES — $639.2K across 42 shipments (7.1% of this supplier's total exports)

• TO THE ORDER — $129.8K across 8 shipments (1.4% of this supplier's total exports)

• ALPHAPHARM PTY LIMIT — $122.6K across 8 shipments (1.4% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (589 shipments) at a per-shipment value of $15.4K, indicating a broad distribution network with many smaller, regular orders.

3STERIL-GENE LIFE SCIENCES PRIVATE LIMITED

STERIL-GENE LIFE SCIENCES PRIVATE LIMITED is the third-largest Levothyroxine exporter from India, with a market share of 11.4% and a total export value of $8.9M across 206 shipments. Their average shipment value of $43.1K is above the market average of $32.6K, suggesting premium or bulk contract pricing.

STERIL-GENE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. BONAPHARM S.A.C.. is the dominant customer, accounting for 88.8% of this supplier's tracked business. Top customers include:

• BONAPHARM S.A.C.. — $7.9M across 183 shipments (88.8% of this supplier's total exports)

• BONAPHARM S.A.C.. — $551.1K across 13 shipments (6.2% of this supplier's total exports)

• MIEN BAC NACOPHARM C — $273.2K across 6 shipments (3.1% of this supplier's total exports)

• BONAPHARM S.A.C.. — $105.3K across 2 shipments (1.2% of this supplier's total exports)

• M/S. LLOYD LABORATOR — $59.9K across 1 shipments (0.7% of this supplier's total exports)

Key Insight: STERIL-GENE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $43.1K is 32% above the market average of $32.6K, consistent with large-order contracts or value-added formulations.

4WOCKHARDT LIMITED

WOCKHARDT LIMITED is the fourth-largest Levothyroxine exporter from India, with a market share of 5.3% and a total export value of $4.1M across 103 shipments. Their average shipment value of $40.0K is above the market average of $32.6K, suggesting premium or bulk contract pricing.

WOCKHARDT LIMITED serves 1 named buyer in our database. WOCKHARDT UK LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• WOCKHARDT UK LIMITED — $4.1M across 103 shipments (100.0% of this supplier's total exports)

Key Insight: WOCKHARDT LIMITED's per-shipment value of $40.0K is 23% above the market average of $32.6K, consistent with large-order contracts or value-added formulations.

5SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Levothyroxine exporter from India, with a market share of 4.9% and a total export value of $3.8M across 119 shipments. Their average shipment value of $32.2K is below the market average of $32.6K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. SUN PHARMA ANZ PTY LIMITED is the dominant customer, accounting for 57.0% of this supplier's tracked business. Top customers include:

• SUN PHARMA ANZ PTY LIMITED — $2.2M across 68 shipments (57.0% of this supplier's total exports)

• SUN PHARMA ANZ PTY LIMITED — $1.5M across 46 shipments (39.0% of this supplier's total exports)

• SUN PHARMA ANZ PTY LIMITED — $152.9K across 5 shipments (4.0% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (119 shipments) at a per-shipment value of $32.2K, indicating a broad distribution network with many smaller, regular orders.

6ACME GENERICS PRIVATE LIMITED

ACME GENERICS PRIVATE LIMITED is the fifth-largest Levothyroxine exporter from India, with a market share of 4.1% and a total export value of $3.2M across 190 shipments. Their average shipment value of $16.8K is below the market average of $32.6K, reflecting a high-volume, competitive pricing strategy.

ACME GENERICS PRIVATE LIMITED serves 5 named buyers in our database. ALEMBIC PHARMACEUTICALS SPA is the dominant customer, accounting for 51.7% of this supplier's tracked business. Top customers include:

• ALEMBIC PHARMACEUTICALS SPA — $1.7M across 98 shipments (51.7% of this supplier's total exports)

• CRESCENT PHARMA LIMITED — $896.0K across 53 shipments (28.0% of this supplier's total exports)

• PHARMACEUTICAL TECHN — $363.3K across 22 shipments (11.4% of this supplier's total exports)

• ALEMBIC PHARMACEUTICALS SPA — $185.7K across 11 shipments (5.8% of this supplier's total exports)

• NORTH LIFE PHARMA EC — $102.2K across 6 shipments (3.2% of this supplier's total exports)

Key Insight: ACME GENERICS PRIVATE LIMITED operates with high shipment frequency (190 shipments) at a per-shipment value of $16.8K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Levothyroxine imports from India, with a total trade value of $49.4M across 677 shipments — representing a 63.6% share of all Levothyroxine exports. The average shipment value of $73.0K is above the global average of $32.6K, indicating high-value procurement contracts or branded formulations. This market is served by 12 tracked buyers.

Named Levothyroxine importers in United States: MACLEODS PHARMA USA,INC, is the largest buyer, accounting for 43.8% ($21.6M) of this market's total imports.

• MACLEODS PHARMA USA,INC, — $21.6M (43.8% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES,LLC — $8.9M (18.1% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES LLC — $3.2M (6.5% of United States's total)

Key Insight: United States's per-shipment average of $73.0K (124% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Levothyroxine imports from India.

Primary Market

Secondary Market

2Peru

Peru ranks as the second-largest destination for Levothyroxine imports from India, with a total trade value of $9.0M across 24 shipments — representing a 11.6% share of all Levothyroxine exports. The average shipment value of $374.6K is above the global average of $32.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Levothyroxine importers in Peru: BONAPHARM S.A.C.. is the largest buyer, accounting for 88.8% ($8.0M) of this market's total imports.

• BONAPHARM S.A.C.. — $8.0M (88.8% of Peru's total)

Key Insight: Peru's per-shipment average of $374.6K (1051% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Peru is a key market for Levothyroxine imports from India.

Primary Market

Secondary Market

3United Kingdom

United Kingdom ranks as the third-largest destination for Levothyroxine imports from India, with a total trade value of $6.8M across 197 shipments — representing a 8.8% share of all Levothyroxine exports. The average shipment value of $34.7K is above the global average of $32.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Levothyroxine importers in United Kingdom: WOCKHARDT UK LIMITED is the largest buyer, accounting for 86.5% ($5.9M) of this market's total imports.

• WOCKHARDT UK LIMITED — $5.9M (86.5% of United Kingdom's total)

• CRESCENT PHARMA LIMITED — $926.4K (13.5% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $34.7K (7% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Levothyroxine imports from India.

Primary Market

Secondary Market

4Australia

Australia ranks as the fourth-largest destination for Levothyroxine imports from India, with a total trade value of $5.3M across 121 shipments — representing a 6.9% share of all Levothyroxine exports. The average shipment value of $44.2K is above the global average of $32.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Levothyroxine importers in Australia: SUN PHARMA ANZ PTY LTD is the largest buyer, accounting for 65.2% ($3.5M) of this market's total imports.

• SUN PHARMA ANZ PTY LTD — $3.5M (65.2% of Australia's total)

• SUN PHARMA ANZ PTY LIMITED — $1.5M (28.0% of Australia's total)

Key Insight: Australia's per-shipment average of $44.2K (36% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Levothyroxine imports from India.

Primary Market

Secondary Market

5Chile

Chile ranks as the fifth-largest destination for Levothyroxine imports from India, with a total trade value of $1.8M across 21 shipments — representing a 2.4% share of all Levothyroxine exports. The average shipment value of $87.6K is above the global average of $32.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Levothyroxine importers in Chile: ALEMBIC PHARMACEUTICALS SPA is the largest buyer, accounting for 89.9% ($1.7M) of this market's total imports.

• ALEMBIC PHARMACEUTICALS SPA — $1.7M (89.9% of Chile's total)

Key Insight: Chile's per-shipment average of $87.6K (169% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Chile is a key market for Levothyroxine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Levothyroxine.
2.Flow Mapping: 125 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,385 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 71 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,385 Verified Shipments

125 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Levothyroxine

Levothyroxine

Who Supplies Levothyroxine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Levothyroxine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Levothyroxine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MACLEODS PHARMACEUTICALS LTD

2INTAS PHARMACEUTICALS LIMITED

3STERIL-GENE LIFE SCIENCES PRIVATE LIMITED

4WOCKHARDT LIMITED

5SUN PHARMACEUTICAL INDUSTRIES LIMITED

6ACME GENERICS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Levothyroxine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Levothyroxine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Peru

3United Kingdom

4Australia

5Chile

People Also Ask — Levothyroxine Supplier & Trade Network

Levothyroxine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology